News

Patent Enforcement Notice

Cease & Desist notice issued to owners of a Colorado-based website, www.pingueculaeyedrops.com which was infringing Ocular Discovery’s US patents by offering dipyridamole-containing eye drops. The infringers have ceased sales of their infringing product and transferred ownership of their domains to Ocular Discovery Ltd.

Read More

Fifth U.S. Patent Granted

Fifth patent allowance issued in the United States, toward the use of topical dipyridamole for the treatment of melanocytic nevus, cataracts, and ocular melanoma.

Read More

Fourth U.S. Patent Granted

Fourth patent allowance issued in the United States, the for the use of dipyridamole in the following indications: keratitis, corneal abrasions, and corneal ulcers

Read More

Patent Granted in China

Patent allowance issued in China for the indications of Dry Eye Disease, Sjogren’s Syndrome, Pterygium,  Pinguecula, and Corneal Neovascularization

Read More